Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Seven additional Phase 3 readouts are expected through the remainder of the year, covering applications in type 2 diabetes, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and metabolic liver disease
The presence of the biofilm phenotype contributes to diagnostic and treatment challenges, including considerably increased antibiotic tolerance and treatment failure leading to additional surgeries, amputation, and death is not uncommon (3)
TNF- receptor inhibitor alleviates metabolic and inflammatory changes in a rat model of ischemic stroke
The key inflammatory markers in brain injury include interleukin-1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6)
